ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,496 | -39.5% | 17,272 | -22.4% | 0.00% | – |
| Q2 2023 | $172,800 | +561.8% | 22,268 | +402.3% | 0.00% | – |
| Q4 2022 | $26,110 | – | 4,433 | +3233.1% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 133 | -94.0% | 0.00% | – |
| Q2 2022 | $10,000 | -98.9% | 2,204 | -96.5% | 0.00% | – |
| Q4 2021 | $917,000 | +68.6% | 62,399 | +140.1% | 0.00% | – |
| Q3 2021 | $544,000 | +325.0% | 25,986 | +259.0% | 0.00% | – |
| Q2 2021 | $128,000 | -83.4% | 7,239 | -77.0% | 0.00% | – |
| Q1 2021 | $772,000 | +1384.6% | 31,504 | +1963.1% | 0.00% | – |
| Q4 2020 | $52,000 | +30.0% | 1,527 | -5.2% | 0.00% | – |
| Q3 2020 | $40,000 | -58.3% | 1,610 | -43.4% | 0.00% | – |
| Q2 2020 | $96,000 | – | 2,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |